Clinical Trials

If you would like to explore the possibility of participating in a clinical trial at Guthrie, please call 1-800-836-0388.
Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Crohn's Disease
Department: Gastroenterology
Diagnosis: Gastrointestinal - Crohn's
Principal Investigator: Michael J Georgetson, MD
Sponsors: BMS
Details (Indentifier #): NCT03599622
Title: AbbVie M14-234, A Multicenter, Randomized, Double-Blind,
Placebo-Controlled Study to Evaluate the Safety and
Efficacy of ABT-494 for Induction and Maintenance
Therapy in Subjects with Moderately to Severely
Active Ulcerative Colitis
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Michael J Georgetson, MD
Sponsors: AbbVie
Details (Indentifier #): NCT02819635
Title: CHS1221: A Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Safety and Efficacy of Once-Daily and Twice-Daily Dosing of a Novel Hydrocortisone Acetate 90 mg Suppository Formulation Administered with the Sephure® Suppository Applicator in Subjects with Ulcerative Colitis of the Rectum
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Michael J Georgetson, MD
Sponsors: Cristcot
Details (Indentifier #): NCT04469686
Title: ECOSPOR IV: AN OPEN-LABEL EXTENSION OF STUDY SERES-012
EVALUATING SER-109 IN ADULT SUBJECTS WITH RECURRENT
CLOSTRIDIUM DIFFICILE INFECTION (RCDI)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: Michael J Georgetson, MD
Sponsors: Seres
Details (Indentifier #): NCT03183141
Title: Limited access protocol for the use of oral cisapride in the treatment of refractory gastroesophageal reflux disease and other gastrointestinal motility disorders. CIS-USA-154
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: Thomas J McDonald, MD
Sponsors: Janssen
Details (Indentifier #): none
Title: M14-533, A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Michael J Georgetson, MD
Sponsors: AbbVie
Details (Indentifier #): NCT03006068
Title: Protocol SMT19969/C005 (Ri-CoDIFy 2): A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of ridinilazole (200 mg, bid) for 10 days with vancomycin (125 mg, qid) for 10 days in the treatment
of Clostridium difficile infection (CDI)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: Michael J Georgetson, MD
Sponsors: Summit
Details (Indentifier #): NCT03595566